THE EVALUATION OF CLINICAL AND LABORATORY FINDINGS OF THE PATIENTS ON CAPD TREATMENT BETWEEN 1992-1996

In this study 30 patients with end stage rena disease were discussed in point of clinical, laboratory outcomes, adequecy and complications who underwent CAPD treatment during the last 4 years. 16 female, 14 male patients were followed up 52.46+23.46 weeks in average and their mean age was 54.16±13.15 years. Their serum BUN, creatinine, uric acid, calcium, phosphorus and electrolyte levels were controlled properly. Their clinical outcomes were excellent and most of them returned to their previous life. Uremic symptoms disappeared. The control of hypertension became easy, even some patients stopped using antihypertensive drugs. Anemia were treated with EPO in only 19 patients; the other 11 patients hematological values became normal without using any treatment. Hypoalbuminemia and malnutrition were not a problem during the follow up period. Hyperlipidemia called attention, but renal osteodystrophy and neuropathy did not seem to cause any problem during this period of time. Peritonitis was still the most serious problem we had to deal. We experienced 1.5 peritonitis attacks every year. The most common responsible agent was staphylococcus aureus (16.3%). As a result; 3 of our case was died, 2 of them had cerebrovascular accident, the other one had fungal peritonitis. 3 out of 30 returned to hemodialysis treatment because of fungal peritonitis. 2 received renal transplantation. The rest of them continue to follow up. Even though treatment has a lot of advantages, peritonitis still keeps its place as a serious complication in our country. The education of patients and its family, the relationship and communication between patients, doctors, nurses and other workers seems very important subjects to lower this complication.